UPDATE
: Thursday, December 5, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market
Interleukin inhibitors are rising as the newest psoriasis treatment.Tumor n...
by Kim Yun-mi
|
2019-03-26 14:56
라인
[Special] PCSK9 inhibitors aim to replace statin in cholesterol reduction
Amgen's dyslipidemia treatment Repatha (right) and Sanofi's Praluen...
by Kim Yun-mi
|
2019-03-18 15:49
-
1
-
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
여백
Most viewed
1
Syntekabio views industry’s crisis as opportunity
2
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
3
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
4
Technology developed to detect inflammatory disorders early
5
GC MS wins US patent for influenza diagnostic technology
6
‘Obesity needs to be treated as a chronic disease’
7
Alteogen inks licensing-out deal for SC injection formulation technology
8
[Special] Trainee doctors fear medical mishaps amid severe shortage of workforce
9
Samyang Biopharm’s US subsidiary to work on new immunotherapy
10
Swedish researchers divide Type 2 diabetes into 5 subgroups
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top